Aristides Capital’s Outset Medical OM Stock Holding History

Aristides Capital’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-47,700	Closed	-$177K	–	249
2025 Q4	$177K	Buy	+47,700	New	+$409K	0.03%	214

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aristides Capital's OM Position: Q1 2026 in Review

Aristides Capital sold out of Outset Medical (OM) in Q1 2026, closing a stake of 47,700 shares — an estimated $177K sold.

Aristides Capital first reported a position in OM in Q4 2025 and held it in 1 quarter. The position peaked at $177K in Q4 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

Aristides Capital reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
Aristides Capital sold 47,700 Outset Medical shares in Q1 2026, an estimated $177K.
Aristides Capital first reported a position in Outset Medical in Q4 2025 and held it in 1 quarter.
Aristides Capital's Outset Medical position peaked at $177K in Q4 2025.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.